Generic Xeloda Now Available

Last week, the Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat metastatic colorectal cancer.

Kathleen Uhl, M.D., acting director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research, says “Generic drugs are important options that allow greater access to health care for all Americans. This medication is widely used by people living with cancer, so it is important to have access to affordable treatment options.”

Teva Pharmaceuticals will be the new manufacturer of the generic capecitabine. Availability of the generic on the market has yet to be determined.

Read the release from the FDA about generic Xeloda.

What does this mean for you?

Our team at Fight Colorectal Cancer is pleased to see this advancement of the generic form of Xeloda. Generic drugs are generally less expensive than brand-name drugs and are deemed to be equivalent in patient benefit.

If you are using Xeloda, we encourage you to ask your doctor about the generic version.

If you have questions or need help, please contact our Answer Line.